Paclitaxel (Aibumin-Bound)

Common brands: Abraxane, Paclitaxel, Paclitaxel Paclitaxel, Paclitaxel Protein Bound Particles Albumin Bound, Paclitaxel Protein-Bound Particles For Injectable Suspension (Albumin-Bound)

Top reporter: Abraxis Bioscience, Llc

Microtubule Inhibitor [EPC]Platinum-based Drug [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]HER2/neu Receptor Antagonist [EPC]
79,282
Total Reports
43,516
Serious Reports
11,097
Death Reports
30
Reported Reactions
Death Report Ratio: High (14.00%)

Patient Demographics

Male
17,733
Female
50,496

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Paclitaxel (Aibumin-Bound).

# Reaction Reports % of Total
1 NAUSEA 4,518
5.6%
2 DYSPNOEA 4,517
5.6%
3 NEUTROPENIA 4,400
5.4%
4 OFF LABEL USE 4,278
5.3%
5 DIARRHOEA 4,184
5.2%
6 ANAEMIA 3,855
4.8%
7 MALIGNANT NEOPLASM PROGRESSION 3,607
4.5%
8 DISEASE PROGRESSION 3,335
4.1%
9 FATIGUE 3,306
4.1%
10 NEUROPATHY PERIPHERAL 3,180
3.9%
11 MYELOSUPPRESSION 3,136
3.9%
12 PYREXIA 3,094
3.8%
13 VOMITING 3,047
3.8%
14 FEBRILE NEUTROPENIA 3,030
3.7%
15 DRUG INEFFECTIVE 2,512
3.1%
16 ASTHENIA 2,439
3.0%
17 THROMBOCYTOPENIA 2,277
2.8%
18 DEATH 2,106
2.6%
19 RASH 2,094
2.6%
20 ERYTHEMA 1,956
2.4%
21 DECREASED APPETITE 1,825
2.3%
22 HYPERTENSION 1,781
2.2%
23 PNEUMONIA 1,668
2.1%
24 NEUTROPHIL COUNT DECREASED 1,618
2.0%
25 ABDOMINAL PAIN 1,570
1.9%
26 FLUSHING 1,540
1.9%
27 BACK PAIN 1,520
1.9%
28 LEUKOPENIA 1,492
1.8%
29 WHITE BLOOD CELL COUNT DECREASED 1,491
1.8%
30 GENERAL PHYSICAL HEALTH DETERIORATION 1,463
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.